Fidji Simo, the executive OpenAI hired to turn its research breakthroughs into actual products people use, is stepping down from her full-time role to focus on recovering from a chronic illness. She’ll stay on in a part-time advisory capacity, but the day-to-day leadership of OpenAI’s applications division is effectively changing hands.
What happened and why it matters
Simo’s departure from full-time duties stems from Postural Orthostatic Tachycardia Syndrome, or POTS, a neurological condition that affects blood flow and can cause debilitating fatigue, dizziness, and cognitive difficulties. She announced a medical leave in April 2026 after what she described as a relapse over the preceding month.
Her trajectory at OpenAI was steep and deliberate. She first joined the company’s board in March 2024, then assumed the newly created role of CEO of Applications in August 2025. Before OpenAI, Simo spent a decade at Meta (formerly Facebook) and then served as CEO of Instacart from 2021 to 2025.
Under her watch, OpenAI was attempting to shift its center of gravity from pure research toward scaling consumer and enterprise applications, during a period when the organization was reportedly burning through roughly $5 billion in annual losses.
